Skip to main content


Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.

  • Thursday, Oct 12th
    8:00 AM – 9:30 AM PDT
    Cancer Drug Delivery and Nanotechnology I
    Location: 342 (Center, Level 3)
    Track Chair: Jan Lammerding, PhD (he/him/his) – Cornell University
    Track Chair: Jessica Winter – The Ohio State University
    Moderator: Daniel Hayes – Pennsylvania State University
    Moderator: Anandi Krishnan, PhD (she/her/hers) – Stanford University - School of Medicine
    Cancer Technologies
  • Thursday, Oct 12th
    8:00 AM – 9:30 AM PDT
    Tumor Microenvironment
    Location: 343 (Center, Level 3)
    Track Chair: Jan Lammerding, PhD (he/him/his) – Cornell University
    Track Chair: Jessica Winter – The Ohio State University
    Moderator: Walter L. Murfee – University of Florida
    Moderator: Catherine F. Whittington – Worcester Polytechnic Institute
    Cancer Technologies
  • Thursday, Oct 12th
    8:00 AM – 8:15 AM PDT
    A nanotherapeutic strategy to target drug-tolerant cells and overcome EGFR tyrosine kinase inhibitor resistance in lung cancer
    Location: 342 (Center, Level 3)
    Presenting Author: Yafei Su (she/her/hers) – University at Buffalo, The State University of New York
    Co-Author: Tatiana Shaurova – Roswell Park Comprehensive Cancer Center
    Co-Author: Lingyue Yan – University at Buffalo, The State University of New York
    Co-Author: Laurie J Rich – FUJIFILM VisualSonics, Inc
    Co-Author: Vui King Vincent-Chong – Roswell Park Comprehensive Cancer Center
    Co-Author: Hannah Calkins – Roswell Park Comprehensive Cancer Center
    Co-Author: Saraswati Pokharel – Roswell Park Comprehensive Cancer Center
    Co-Author: Martin Petkovich – Queens University
    Co-Author: Mukund Seshadri – Roswell Park Comprehensive Cancer Center
    Primary Investigator: Yun Wu, PhD – University at Buffalo, The State University of New York
    Last Author: Pamela A Hershberger – Roswell Park Comprehensive Cancer Center
    Cancer Technologies
  • Thursday, Oct 12th
    8:00 AM – 8:15 AM PDT
    Elucidating the Effects of TAM Receptors in Tumor-Immune Cell Crosstalk
    Location: 343 (Center, Level 3)
    Presenting Author: Anisha Datta (she/her/hers) – Massachusetts Institute of Technology
    Primary Investigator: Douglas Lauffenburger – Massachusetts Institute of Technology
    Cancer Technologies
  • Thursday, Oct 12th
    8:15 AM – 8:30 AM PDT
    Applying activity-based nanotechnologies towards lung cancer interception
    Location: 342 (Center, Level 3)
    Presenting Author: Cathy Wang – Massachusetts Institute of Technology
    Co-Author: Qian Zhong – MIT
    Co-Author: Shih-Ting Wang, PhD (she/her/hers) – Massachusetts Institute of Technology
    Co-Author: Carmen Martin Alonso (she/her/hers) – Massachussetts Institute of Technology / Harvard University
    Co-Author: Tiziana Parisi – MIT
    Co-Author: Sahil Patel – Massachusetts Institute of Technology
    Co-Author: Tyler Jacks – MIT
    Primary Investigator: Sangeeta Bhatia – Massachusetts Institute of Technology
    Cancer Technologies
  • Thursday, Oct 12th
    8:15 AM – 8:30 AM PDT
    Biophysical Properties of Hyaluronic Acid Differentially Regulate Breast Cancer Invasion In Single Cells vs. Spheroids
    Location: 343 (Center, Level 3)
    Presenting Author: Brittany Schutrum (she/her/hers) – Cornell University
    Co-Author: Adrian Shimpi – Cornell University
    Co-Author: Matthew Tan – Cornell University
    Co-Author: Meg McFetridge – Cornell University
    Co-Author: Santosh Balakrishnan – Cornell University
    Co-Author: Daniel Rivera – Cornell University
    Co-Author: Steven Adie – Cornell University
    Co-Author: Chris Schaffer – Cornell University
    Co-Author: Nozomi Nishimura – Cornell University
    Co-Author: Matthew Paszek – Cornell University
    Primary Investigator: Claudia Fischbach – Cornell University
    Cancer Technologies
  • Thursday, Oct 12th
    8:30 AM – 8:45 AM PDT
    The role of hypertrophic adipocytes in breast cancer progression
    Location: 343 (Center, Level 3)
    Presenting Author: Garrett F. Beeghly, MS (he/him/his) – Cornell University
    Co-Author: Dong Wang – Yale University
    Co-Author: Yitong Zheng – Yale University
    Co-Author: Neil Iyengar – Memorial Sloan Kettering Cancer Center
    Co-Author: Corey O'Hern – Yale University
    Primary Investigator: Claudia Fischbach – Cornell University
    Cancer Technologies
  • Thursday, Oct 12th
    8:30 AM – 8:45 AM PDT
    Microdissected “cuboids” as a model system for cancer drug testing
    Location: 342 (Center, Level 3)
    Presenting Author: Lisa Horowitz, MD PhD – University of Washington
    Co-Author: Tran N. H Nguyen, PhD (she/her/hers) – Department of Bioengineering/University of Washington
    Co-Author: Ethan Lockhart (he/him/his) – University of Washington
    Co-Author: Ricard Rodriguez – University of Washington
    Co-Author: Chuan Bian Lim – Human Biology Division, Fred Hutchinson Cancer Research Center
    Co-Author: Heidi Kenerson – University of Washington
    Co-Author: Judit Villen – University of Washington
    Co-Author: Raymond S Yeung, MD – University of Washington
    Co-Author: Taranjit Gujral – Human Biology Division, Fred Hutchinson Cancer Research Center
    Last Author: Albert Folch (he/him/his) – University of Washington
    Cancer Technologies
  • Thursday, Oct 12th
    8:45 AM – 9:00 AM PDT
    Mitochondrial Transfer of Cancer Associated Fibroblast Increases Breast Cancer Invasion
    Location: 343 (Center, Level 3)
    Presenting Author: Emily D. Berestesky, BS (she/her/hers) – Department of Biomedical Engineering, Vanderbilt University, Nashville, TN
    Co-Author: Kayla F. Goliwas, PhD (she/her/hers) – Department of Medicine, University of Alabama at Birmingham, Birmingham, AL
    Co-Author: Jian Zhang, PhD (he/him/his) – Department of Biomedical Engineering, University of Arkansas, Fayetteville, AR
    Co-Author: Sarah Libring, PhD (she/her/hers) – Department of Biomedical Engineering, Vanderbilt University, Nashville, TN
    Co-Author: Shayan Gholizadeh, PhD (he/him/his) – Department of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY
    Co-Author: Samantha S. Schwager, PhD (she/her/hers) – Department of Biomedical Engineering, Vanderbilt University, Nashville, TN
    Co-Author: Andra R. Frost, MD (she/her/hers) – Department of Pathology, University of Alabama at Birmingham, Birmingham, AL
    Co-Author: Thomas Gaborski, PhD – Department of Biomedical Engineering, Rochester Institute of Technology, Rochester, NY
    Last Author: Cynthia Reinhart-King, PhD (she/her/hers) – Department of Biomedical Engineering, Vanderbilt University, Nashville, TN
    Cancer Technologies
  • Thursday, Oct 12th
    8:45 AM – 9:00 AM PDT
    Stroma Affects the Intratumoral Transport of Bacteria-Based Cancer Therapy
    Location: 342 (Center, Level 3)
    Co-Author: Ying Zhan – Virginia Tech
    Co-Author: Brian Burkel – University of Wisconsin
    Co-Author: Suzanne Ponik – University of Wisconsin
    Presenting Author: Bahareh Behkam, PhD (she/her/hers) – Virginia Tech
    Cancer Technologies
  • Thursday, Oct 12th
    9:00 AM – 9:15 AM PDT
    Investigating the Role of Collagen-Binding Integrins in 3D Breast Cancer Spheroid Migration Models
    Location: 343 (Center, Level 3)
    Presenting Author: Jordan N. Miner (she/her/hers) – University of Maine
    Co-Author: Zoe Vittum – University of Maine
    Co-Author: Peter Brooks – MaineHealth Institute for Research
    Co-Author: Andre Khalil – University of Maine
    Co-Author: Karissa Tilbury – University of Maine
    Cancer Technologies
  • Thursday, Oct 12th
    9:00 AM – 9:30 AM PDT
    Engineering the gut microbiome and immune system to improve cancer immunotherapy
    Location: 342 (Center, Level 3)
    Presenting Author: James Moon, PhD – University of Michigan, Ann Arbor
    Cancer Technologies
  • Thursday, Oct 12th
    9:15 AM – 9:30 AM PDT
    Investigating the combined effects of matrix stiffness and pancreatic-adipose crosstalk in directing pancreatic cancer initiation and progression
    Location: 343 (Center, Level 3)
    Presenting Author: Athenia E. Jones (she/her/hers) – Worcester Polytechnic Institute
    Primary Investigator: Catherine F. Whittington – Worcester Polytechnic Institute
    Co-Author: Gianluca Panza – Worcester Polytechnic Institute
    Cancer Technologies
  • Thursday, Oct 12th
    12:30 PM – 2:00 PM PDT
    Cancer Drug Delivery and Nanotechnology II
    Location: 340 (Center, Level 3)
    Track Chair: Jan Lammerding, PhD (he/him/his) – Cornell University
    Track Chair: Jessica Winter – The Ohio State University
    Moderator: Richard Heller, PhD – University of South Florida
    Moderator: Jyothi Menon – University of Rhode Island
    Cancer Technologies
  • Thursday, Oct 12th
    12:30 PM – 2:00 PM PDT
    Computational Modeling of Cancer and Systems Biology
    Location: 341 (Center, Level 3)
    Track Chair: Jan Lammerding, PhD (he/him/his) – Cornell University
    Track Chair: Jessica Winter – The Ohio State University
    Moderator: Ioannis Zervantonakis (he/him/his) – University of Pittsburgh
    Moderator: Sepideh Dolatshahi, PhD – University of Virgina, Charlottesville
    Cancer Technologies
  • Thursday, Oct 12th
    12:30 PM – 12:45 PM PDT
    Prostate Specific Membrane Antigen Targeted Photodynamic Therapy Agent for the Treatment of Breast Cancer
    Location: 340 (Center, Level 3)
    Presenting Author: Aditi A. Shirke, BSE (she/her/hers) – Case Western Reserve University
    Co-Author: Xinning Wang (she/her/hers) – Case Western Reserve University
    Primary Investigator: James Basilion (he/him/his) – Case Western Reserve University
    Cancer Technologies
  • Thursday, Oct 12th
    12:30 PM – 12:45 PM PDT
    Progressive and predictive markers of disease evolution: platelet transcriptome in chronic myeloproliferative neoplasms
    Location: 341 (Center, Level 3)
    Co-Author: Zhu Shen – Harvard University
    Co-Author: Wenfei Du – Amazon
    Co-Author: Cecelia Perkins – Stanford University
    Co-Author: Lenn Fechter – Stanford University
    Co-Author: Vanita Natu – Stanford University
    Co-Author: Holden Maecker – Stanford University
    Co-Author: Jesse Rowley – University of Utah
    Co-Author: Jason Gotlib – Stanford University School of Medicine
    Co-Author: James Zehnder – Stanford University School of Medicine
    Presenting Author: Anandi Krishnan, PhD (she/her/hers) – Stanford University - School of Medicine
    Cancer Technologies
  • Thursday, Oct 12th
    12:45 PM – 1:00 PM PDT
    Clinical combination therapy optimization through personalized mechanistic models
    Location: 341 (Center, Level 3)
    Presenting Author: Lindsey Fernandez, PhD (she/her/hers) – University of Pennsylvania
    Co-Author: Kewei Ni (she/her/hers) – University of Pennsylvania
    Co-Author: Sharvari Kemkar (she/her/hers) – University of Pennsylvania
    Co-Author: Alokendra Ghosh (he/him/his) – University of Pennsylvania
    Primary Investigator: Ravi Radhakrishnan, PhD (he/him/his) – University of Pennsylvania
    Cancer Technologies
  • Thursday, Oct 12th
    12:45 PM – 1:00 PM PDT
    Nuclear morphology predicts cell survival to cisplatin chemotherapy
    Location: 340 (Center, Level 3)
    Presenting Author: Chi-Ju Kim, PhD (he/him/his) – Johns Hopkins University School of Medicine
    Co-Author: Anna Gonye – Johns Hopkins University School of Medicine
    Co-Author: Kevin Truskowski – Johns Hopkins University School of Medicine
    Co-Author: Cheng-Fan Lee – Johns Hopkins University School of Medicine
    Co-Author: Yoon-Kyoung Cho – UNIST & IBS
    Co-Author: Robert Austin – Princeton University
    Co-Author: Kenneth Pienta – Johns Hopkins University School of Medicine
    Last Author: Sarah Amend – Johns Hopkins University School of Medicine
    Cancer Technologies
  • Thursday, Oct 12th
    1:00 PM – 1:15 PM PDT
    Ascribing gain, loss, or lack of function to the spontaneous PCSK5 M452I mutation of MCF10DCIS cells, a common engineered model of breast ductal carcinoma in situ.
    Location: 341 (Center, Level 3)
    Presenting Author: Taylor Marohl (she/her/hers) – Department of Biomedical Engineering, University of Virginia
    Co-Author: Lixin Wang – Department of Biomedical Engineering, University of Virginia
    Last Author: Kevin Janes – University of Virginia
    Cancer Technologies
  • Thursday, Oct 12th
    1:00 PM – 1:15 PM PDT
    Characterizing VEGFR-2 Phosphorylation Patterns Due to Strain and Anti-Angiogenic Therapies
    Location: 340 (Center, Level 3)
    Presenting Author: Bronte Miller, MS (she/her/hers) – The University of Alabama at Birmingham
    Co-Author: Michael D. Heim (he/him/his) – The University of Alabama at Birmingham
    Primary Investigator: MK Sewell-Loftin (she/her/hers) – The University of Alabama at Birmingham
    Cancer Technologies
  • Thursday, Oct 12th
    1:15 PM – 1:30 PM PDT
    Engineering Genetic Circuits to Promote Tumor Allorejection for Immunotherapy of Solid Cancers
    Location: 341 (Center, Level 3)
    Presenting Author: Srinivas Balagopal (he/him/his) – Imperial College London
    Co-Author: Sushmita Halder – Dana-Farber Cancer Institute
    Primary Investigator: Ming-Ru Wu – Dana-Farber Cancer Institute
    Cancer Technologies
  • Thursday, Oct 12th
    1:15 PM – 1:30 PM PDT
    Formulation Development of a Conjugatable Junction Opener Protein for DSG2 Positive Tumor Disruption
    Location: 340 (Center, Level 3)
    Presenting Author: Adrian Simpson – HDT Bio
    Primary Investigator: Amit P. Khandhar, PhD (he/him/his) – HDT Bio
    Co-Author: Jiho Kim – PAI Life Sciences
    Co-Author: Darrick Carter – PAI Life Sciences
    Co-Author: Jim Reed – HDT Bio
    Cancer Technologies
  • Thursday, Oct 12th
    1:30 PM – 1:45 PM PDT
    A novel non-apoptotic compound prevents breast cancer intravasation by protecting endothelial cells in a microfluidic model
    Location: 340 (Center, Level 3)
    Presenting Author: Indira Sigdel (she/her/hers) – University of Toledo
    Co-Author: Awurama Ofori-Kwafo (she/her/hers) – University of Toledo
    Co-Author: Khalid Khalaf (he/him/his) – University of Toledo
    Co-Author: Andrea Nestor-Kalinoski (she/her/hers) – University of Toledo
    Co-Author: Amit K. Tiwari (he/him/his) – University of Toledo
    Last Author: Yuan Tang (he/him/his) – University of Toledo
    Cancer Technologies
  • Thursday, Oct 12th
    1:30 PM – 2:00 PM PDT
    Agent-based modeling predicts evolution of the tumor microenvironment in breast cancer
    Location: 341 (Center, Level 3)
    Presenting Author: Stacey Finley (she/her/hers) – University of Southern California
    Cancer Technologies
  • Thursday, Oct 12th
    1:45 PM – 2:00 PM PDT
    Acquired temozolomide resistance instructs patterns of glioblastoma cell motility, pro-angiogenic cytokine production, and response to repeated drug exposure in gelatin hydrogels
    Location: 340 (Center, Level 3)
    Presenting Author: Victoria Kriuchkovskaia – University of Illinois Urbana-Champaign
    Co-Author: Rebecca B. Riggins – Georgetown University
    Primary Investigator: Brendan A.C. Harley – Department of Chemical and Biomolecular Engineering, University of Illinois Urbana Champaign
    Cancer Technologies
  • Thursday, Oct 12th
    3:00 PM – 4:30 PM PDT
    Cancer Mechanobiology
    Location: 339 (Center, Level 3)
    Track Chair: Jan Lammerding, PhD (he/him/his) – Cornell University
    Track Chair: Jessica Winter – The Ohio State University
    Moderator: Indrajit Sriastava – Texas Tech University
    Moderator: Panagiotis Mistriotis – Auburn University
    Cancer Technologies
  • Thursday, Oct 12th
    3:00 PM – 3:15 PM PDT
    KRAS Mutations in Colorectal Cancer Drive a Unique Mechanotransduction Response to Peristalsis-Associated Forces
    Location: 337 (Center, Level 3)
    Presenting Author: Abbie J. Clevenger (she/her/hers) – Texas A&M University Biomedical Engineering Department
    Co-Author: Maygan McFarlin – Texas A&M University Biomedical Engineering
    Co-Author: Anirudh Madyastha – Texas A&M University Biomedical Engineering
    Co-Author: John Paul Gorley – Texas A&M University Biomedical Engineering
    Primary Investigator: Shreya A. Raghavan – Texas A&M University Biomedical Engineering
    Cancer Technologies
  • Thursday, Oct 12th
    3:15 PM – 3:30 PM PDT
    Extracellular matrix cues combine to generate diverse phenotypes during breast cancer progression
    Location: 337 (Center, Level 3)
    Presenting Author: Abhishek Sharma, MSc. (he/him/his) – University of California Santa Barbara
    Co-Author: Rowan Steger – University of California Santa Barbara
    Co-Author: Kellie Heom – University of California Santa Barbara
    Last Author: Siddharth Dey – University of California Santa Barbara
    Primary Investigator: Ryan Stowers – University of California, Santa Barbara
    Cancer Technologies
  • Thursday, Oct 12th
    3:30 PM – 3:45 PM PDT
    A microfluidic stiffness gradient gel platform for probing cancer cell invasion into the extracellular matrix
    Location: 337 (Center, Level 3)
    Presenting Author: Martin Kiwanuka, MSc (he/him/his) – Mechanobiology Institute, National University of Singapore
    Co-Author: Jyothsna Vasudevan, n/a – Mechanobiology Institute, National University of Singapore, Singapore; Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research, Singapore
    Co-Author: Hepi H. Susapto – Mechanobiology Institute, National University of Singapore, Singapore
    Co-Author: Samuel Maher – School of Human Sciences, The University of Western Australia, Perth, WA, Australia
    Co-Author: Yu Suk Choi – School of Human Sciences, The University of Western Australia, Perth, WA, Australia
    Co-Author: Yongsung Hwang – Soonchunhyang Institute of Medi-bio Science, Soonchunhyang University, Cheonan-si, Chungcheongnam-do, 31151, Korea
    Co-Author: Khoon S. Lim – School of Medical Sciences, University of Sydney, Sydney, NSW 2006, Australia
    Co-Author: Andrea Pavesi – Mechanobiology Institute, National University of Singapore, Singapore; Institute of Molecular and Cell Biology, Agency for Science, Technology, and Research, Singapore
    Last Author: Jennifer L. Young – Mechanobiology Institute, National University of Singapore, Singapore; Department of Biomedical Engineering, National University of Singapore, Singapore
    Cancer Technologies
  • Thursday, Oct 12th
    3:45 PM – 4:00 PM PDT
    Detection of biomechanical alterations in the left ventricle due to radiation-induced cardiotoxicity
    Location: 337 (Center, Level 3)
    Presenting Author: Tanmay Mukherjee, MS – Texas A&M University
    Co-Author: Sarah Elliott – University of Texas Southwestern Medical Center
    Co-Author: Nandhini Manikandan – Texas A&M University
    Co-Author: Janaka Wansapura – University of Texas Southwestern Medical Center
    Co-Author: Prasanna Alluri – University of Texas Southwestern Medical Center
    Primary Investigator: Reza Avazmohammadi – Texas A&M University
    Cancer Technologies
  • Thursday, Oct 12th
    4:00 PM – 4:15 PM PDT
    Adhesion Strength of Stromal-Resident Tumor Cells Predicts Metastatic Disease in vivo
    Location: 337 (Center, Level 3)
    Presenting Author: Madison Kane – University of California, San Diego
    Co-Author: Katherine Birmingham, PhD – BD Biosciences
    Co-Author: Benjamin Yeoman, PhD – Altos Labs
    Co-Author: Pranjali Beri, PhD – Vertex Pharmaceuticals
    Co-Author: Isabelle Williams – Rice University
    Co-Author: Aditya Kumar, PhD – Altos Labs
    Co-Author: Parag Katira, PhD – San Diego State University
    Primary Investigator: Adam Engler, PhD – University of California, San Diego
    Cancer Technologies
  • Friday, Oct 13th
    8:00 AM – 9:30 AM PDT
    Cancer Immunoengineering, Immunomodulation and Immunotherapy I
    Location: 340 (Center, Level 3)
    Track Chair: Jan Lammerding, PhD (he/him/his) – Cornell University
    Track Chair: Jessica Winter – The Ohio State University
    Moderator: Marian Ackun-Farmmer, PhD (she/her/hers) – University of Maryland/Georgia Institute of Technology
    Cancer Technologies
  • Friday, Oct 13th
    8:00 AM – 9:30 AM PDT
    Imaging Strategies in Cancer Detection, Diagnosis, and Prognosis
    Location: 341 (Center, Level 3)
    Track Chair: Jan Lammerding, PhD (he/him/his) – Cornell University
    Track Chair: Jessica Winter – The Ohio State University
    Moderator: Erica Pratt, PhD (she/her/hers) – Boston University
    Moderator: Lih Feng Cheow, PhD (he/him/his) – National University of Singapore
    Cancer Technologies
  • Friday, Oct 13th
    8:00 AM – 8:15 AM PDT
    Early Detection of Human Cancers Using a Cost-Effective, Non-Invasive Assay of the cfDNA Fragmentome
    Location: 341 (Center, Level 3)
    Presenting Author: Akshaya V. Annapragada, SM (she/her/hers) – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Jamie Medina – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Zachariah Foda – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Pien Lof – Department of Gynecologic Oncology, Antoni van Leeuwenhoek Hospital – The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Co-Author: Dimitrios Mathios – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Sarah Short – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Adrianna Bartolomucci – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Daniel Bruhm – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Nicholas Vulpescu – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Euihye Jung – University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Co-Author: Vilmos Adleff – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Heather Symecko – Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Co-Author: Harry Luu – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Daan van de broek – Department of Laboratory Medicine, Antoni van Leeuwenhoek Hospital – The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Co-Author: Stephen Baylin – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Michael Press – Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA
    Co-Author: Dennis Slamon – David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
    Co-Author: Gottffried Konecny – David Geffen School of Medicine, University of California Los Angeles, Los Angeles, CA, USA
    Co-Author: Susan Domchek – Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA
    Co-Author: Ronny Drapkin – University of Pennsylvania School of Medicine, Philadelphia, PA, USA
    Co-Author: Amy Kim – Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland
    Co-Author: Jillian Phallen – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Robert Scharpf – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Co-Author: Christianne Lok – Department of Gynecologic Oncology, Antoni van Leeuwenhoek Hospital – The Netherlands Cancer Institute, Amsterdam, The Netherlands
    Last Author: Victor Velculescu – The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University School of Medicine, Baltimore, MD, USA
    Cancer Technologies
  • Friday, Oct 13th
    8:00 AM – 8:15 AM PDT
    Polymeric nanoparticles alleviate myeloid cell-induced immunosuppression and inhibit metastasis in a material-dependent manner
    Location: 340 (Center, Level 3)
    Presenting Author: Jeffrey A. Ma, MS (he/him/his) – University of Michigan
    Co-Author: Kate V. Griffin – University of Michigan
    Co-Author: Kathryn Kang – University of Michigan
    Co-Author: Ravi M. Raghani – University of Michigan
    Primary Investigator: Lonnie D. Shea – University of Michigan
    Cancer Technologies
  • Friday, Oct 13th
    8:15 AM – 8:30 AM PDT
    A nanoparticle priming agent increases the sensitivity of liquid biopsies
    Location: 341 (Center, Level 3)
    Presenting Author: Carmen Martin Alonso (she/her/hers) – Massachussetts Institute of Technology / Harvard University
    Co-Author: Shervin Tabrizi – Massachusetts Institute of Technology
    Co-Author: Kan Xiong – Broad Institute
    Co-Author: Sahil Patel – Massachusetts Institute of Technology
    Co-Author: Zhenyi An – Broad Institute
    Co-Author: Timothy Blewett – Broad Institute
    Co-Author: Sainetra Sridhar – Broad Institute
    Co-Author: Ava Amini – Microsoft Research
    Co-Author: Jesse Kirkpatrick – Massachusetts Institute of Technology
    Co-Author: Ahmet Bekdemir – Massachusetts Institute of Technology
    Co-Author: Shih-Ting Wang, PhD (she/her/hers) – Massachusetts Institute of Technology
    Co-Author: Justin Rhoades – Broad Institute
    Co-Author: Todd Golub – Broad Institute
    Co-Author: J. Christopher Love – MIT
    Last Author: Viktor Adalsteinsson – Broad Institute
    Primary Investigator: Sangeeta Bhatia – Massachusetts Institute of Technology
    Cancer Technologies
  • Friday, Oct 13th
    8:15 AM – 8:30 AM PDT
    TLI-Ivatar: An In Vitro Model of the Tumor Microenvironment for High Throughput Immunotherapeutic Characterization
    Location: 340 (Center, Level 3)
    Presenting Author: Kristen Shema, MS (she/her/hers) – University of Chicago Pritzker School of Molecular Engineering
    Co-Author: Colleen Foley (she/her/hers) – University of Chicago Pritzker School of Molecular Engineering
    Co-Author: Rachel Weathered (she/her/hers) – UBS Asset Management
    Co-Author: Ruolan Zhou – University of Chicago Pritzker School of Molecular Engineering
    Primary Investigator: Melody Swartz – University of Chicago Pritzker School of Molecular Engineering
    Cancer Technologies
  • Friday, Oct 13th
    8:30 AM – 8:45 AM PDT
    Optimization and Expansion of Digital PCR Multiplexing for Rare Mutation Detection
    Location: 341 (Center, Level 3)
    Presenting Author: Colin Skeen, BS (he/him/his) – Boston University
    Co-Author: Poojitha Sitaram, PhD – Medical College of Wisconsin
    Co-Author: Julia Sexton, BS – University of Minnesota
    Co-Author: Susan Tsai, MD, MHS – Medical College of Wisconsin
    Last Author: Erica Pratt, PhD (she/her/hers) – Boston University
    Cancer Technologies
  • Friday, Oct 13th
    8:30 AM – 8:45 AM PDT
    Discovery of oncolytic peptide CKS1 which induces immunogenic cancer cell death and suppresses tumor growth
    Location: 340 (Center, Level 3)
    Presenting Author: Natsuki Furukawa, MS (he/him/his) – Johns Hopkins University
    Co-Author: Wendy Yang – Johns Hopkins University
    Co-Author: Alex Chao – Johns Hopkins University
    Co-Author: Akash Patil – Johns Hopkins University
    Co-Author: Adam Mirando – Johns Hopkins University
    Co-Author: Niranjan Pandey – Johns Hopkins University
    Primary Investigator: Aleksander Popel – Johns Hopkins University
    Cancer Technologies
  • Friday, Oct 13th
    8:45 AM – 9:00 AM PDT
    Triggering Innate Immune Memory Significantly Increases Survival in a Checkpoint Inhibitor Resistant Tumor Model
    Location: 340 (Center, Level 3)
    Presenting Author: Amy Laflin, M.S. (she/her/hers) – Cornell University
    Co-Author: Erica Wagner – Cornell University
    Primary Investigator: Shaoyi Jiang (he/him/his) – Cornell University
    Cancer Technologies
  • Friday, Oct 13th
    8:45 AM – 9:00 AM PDT
    In vivo Human Colorectal Polyp Evaluation Using an Optical Coherence Tomography Catheter – A Pilot Study
    Location: 341 (Center, Level 3)
    Presenting Author: Haolin Nie, MS (she/her/hers) – Washington University in St. Louis
    Co-Author: Hongbo Luo – Washington University in St. Louis
    Co-Author: Vladimir Lamm – Division of Gastroenterology, Washington University School of Medicine in St. Louis
    Co-Author: Shuying Li – Washington University in St. Louis
    Co-Author: Sanskar Thakur – Washington University in St. Louis
    Primary Investigator: Quing Zhu – Washington University in St. Louis
    Cancer Technologies
  • Friday, Oct 13th
    9:00 AM – 9:15 AM PDT
    Hyperbranched gold nanoconstructs for photoacoustic cancer imaging in the near-infrared optical window
    Location: 341 (Center, Level 3)
    Presenting Author: Myeongsoo Kim (he/him/his) – Georgia Institute of Technology
    Co-Author: Don VanderLaan (he/him/his) – Georgia Institute of Technology
    Co-Author: Jeungyoon Lee – Georgia Institute of Technology
    Co-Author: Ayoung Choe (she/her/hers) – Georgia Institute of Technology College of Engineering
    Co-Author: Kelsey Kubelick, PhD (she/her/hers) – Georgia Institute of Technology
    Last Author: Jinhwan Kim – Georgia Institute of Technology
    Primary Investigator: Stanislav Y. Emelianov – Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology and Emory University School of Medicine
    Cancer Technologies
  • Friday, Oct 13th
    9:00 AM – 9:30 AM PDT
    Data-Driven approaches to cancer nanotechnology development
    Location: 340 (Center, Level 3)
    Presenting Author: Elizabeth Wayne, PhD (she/her/hers) – Carnegie Mellon University
    Cancer Technologies
  • Friday, Oct 13th
    9:15 AM – 9:30 AM PDT
    Heat selection enables highly scalable methylome profiling in cell-free DNA for noninvasive monitoring of cancer patients
    Location: 341 (Center, Level 3)
    Presenting Author: Lih Feng Cheow, PhD (he/him/his) – National University of Singapore
    Co-Author: Elsie Cheruba – National University of Singapore
    Cancer Technologies
  • Friday, Oct 13th
    2:00 PM – 3:30 PM PDT
    Cancer Immunoengineering, Immunomodulation and Immunotherapy II
    Location: 340 (Center, Level 3)
    Track Chair: Jan Lammerding, PhD (he/him/his) – Cornell University
    Track Chair: Jessica Winter – The Ohio State University
    Moderator: Kolade Adebowale, PhD (he/him/his) – Harvard University
    Moderator: Natasha Sheybani
    Cancer Technologies
  • Friday, Oct 13th
    2:00 PM – 3:30 PM PDT
    Engineered Cancer Models for In Vitro Studies I
    Location: 341 (Center, Level 3)
    Track Chair: Jan Lammerding, PhD (he/him/his) – Cornell University
    Track Chair: Jessica Winter – The Ohio State University
    Moderator: Ian Wong – Brown University
    Moderator: Grace G. Bushnell, PhD (she/her/hers) – University of Michigan
    Cancer Technologies
  • Friday, Oct 13th
    2:00 PM – 2:15 PM PDT
    A Bioengineered Leukemia Chip for CAR T-Cell Immunotherapy Modeling and Screening
    Location: 340 (Center, Level 3)
    Presenting Author: Chao Ma, PhD (he/him/his) – New York University Tandon School of Engineering
    Co-Author: Huishu Wang – New York University
    Co-Author: Iannis Aifantis – NYU Grossman School of Medicine
    Co-Author: Saba Ghassemi – Perelman School of Medicine at the University of Pennsylvania
    Last Author: Weiqiang Chen – New York University
    Cancer Technologies
  • Friday, Oct 13th
    2:00 PM – 2:15 PM PDT
    A microphysiological system reveals neutrophil contact-dependent attenuation of pancreatic tumor progression by CXCR2 inhibition-based immunotherapy
    Location: 341 (Center, Level 3)
    Presenting Author: Shuai Shao, MS (he/him/his) – The University of Texas at Dallas
    Primary Investigator: Caroline Jones (she/her/hers) – The University of Texas at Dallas
    Cancer Technologies
  • Friday, Oct 13th
    2:15 PM – 2:30 PM PDT
    3D In-vitro Modeling of CAR-T Cell Infiltration in HER2+ Breast Tumors
    Location: 340 (Center, Level 3)
    Presenting Author: Ruxuan Li (she/her/hers) – University of Pittsburgh
    Primary Investigator: Ioannis Zervantonakis (he/him/his) – University of Pittsburgh
    Co-Author: Jason Lohmueller – University of Pittsburgh
    Cancer Technologies
  • Friday, Oct 13th
    2:15 PM – 2:30 PM PDT
    Patient-Specific Models of the Immune-Competent Tumor and its Microenvironment with Physiological Perfusion
    Location: 341 (Center, Level 3)
    Presenting Author: Sarah Shelton, PHD – North Carolina State University & University of North Carolina-Chapel Hill
    Co-Author: Roger Kamm – Massachusetts Institute of Technology
    Co-Author: David Barbie – Dana-Farber Cancer Institute
    Cancer Technologies
  • Friday, Oct 13th
    2:30 PM – 2:45 PM PDT
    Developing an Engineered In Vitro Bone Niche for Rapid Cell Adhesion and Early-Stage Interactions of Osteoblasts and Metastatic Breast Cancer Cells
    Location: 341 (Center, Level 3)
    Presenting Author: Karen Burg, PhD – University of Georgia
    Co-Author: Timothy Burg, PhD – University of Georgia
    Co-Author: Sara Lewis – University of Georgia
    Co-Author: Arjun Kotapalli – University of Georgia
    Co-Author: Didier Dreau – University of North Carolina at Charlotte
    Cancer Technologies
  • Friday, Oct 13th
    2:30 PM – 2:45 PM PDT
    Tunable Universal OR-gated CAR T cells for Acute Myeloid Leukemia
    Location: 340 (Center, Level 3)
    Presenting Author: Jingyao Chen, PhD (she/her/hers) – Boston University
    Co-Author: Menna Siddiqui – Boston University
    Primary Investigator: Wilson Wong, PhD – Boston University
    Cancer Technologies
  • Friday, Oct 13th
    2:45 PM – 3:00 PM PDT
    Co-delivery of Tumor Antigen with Plant Virus as An Effective Ovarian Cancer Vaccine
    Location: 340 (Center, Level 3)
    Presenting Author: Zhongchao Zhao, PhD (he/him/his) – University of California, San Diego
    Co-Author: Oscar A. Ortega-Rivera – University of California, San Diego
    Co-Author: Young Hun Chung – University of California, San Diego
    Co-Author: Andrea Simms – University of California, San Diego
    Primary Investigator: Nicole Steinmetz – University of California, San Diego
    Cancer Technologies
  • Friday, Oct 13th
    2:45 PM – 3:00 PM PDT
    Live Cell Lineage Tracing of Dormant Cancer Cells
    Location: 341 (Center, Level 3)
    Presenting Author: Hyuna Kim (she/her/hers) – University of Massachusetts Amherst
    Co-Author: Anna Wirasaputra – University of Massachusetts Amherst
    Co-Author: Aritra Nath Kundu – University of Massachusetts Amherst
    Co-Author: Jennifer Esteves – University of Massachusetts Amherst
    Co-Author: Farnaz Mohammadi – University of California, Los Angeles
    Co-Author: Aaron Meyer – University of California, Los Angeles
    Co-Author: Laura Heiser – Oregon Health & Science University
    Primary Investigator: Shelly Peyton – University of Massachusetts Amherst
    Cancer Technologies
  • Friday, Oct 13th
    3:00 PM – 3:15 PM PDT
    Multiplexed Immunofluorescence Imaging for Characterizing Compositional Heterogeneity in Tissue-Engineered 3D in vitro Breast Cancer Tumor Aggregates
    Location: 341 (Center, Level 3)
    Presenting Author: Elizabeth McDonough, MS (she/her/hers) – Rensselaer Polytechnic Institute
    Primary Investigator: David T. Corr, PhD (he/him/his) – Rensselaer Polytechnic Institute
    Cancer Technologies
  • Friday, Oct 13th
    3:00 PM – 3:15 PM PDT
    Generation of transient PD-L1-resistant CAR T cells using dual-encapsulating ionizable lipid nanoparticles
    Location: 340 (Center, Level 3)
    Presenting Author: Alex Hamilton (he/him/his) – University of Pennsylvania
    Last Author: Michael J. Mitchell – University of Pennsylvania
    Cancer Technologies
  • Friday, Oct 13th
    3:15 PM – 3:30 PM PDT
    Tracking Dendritic Cell Vaccination Using Magnetic Particle Imaging
    Location: 340 (Center, Level 3)
    Presenting Author: Bo Yu – University of Florida
    Co-Author: Ginger Moore – University of Florida
    Co-Author: Alexander Armstrong – University of Florida
    Co-Author: Sitong Liu – University of Florida
    Co-Author: Duane Mitchell – University of Florida
    Co-Author: Carlos Rinaldi-Ramos, PhD – University of Florida
    Co-Author: Carlos Bonner – University of Florida
    Cancer Technologies
  • Friday, Oct 13th
    3:15 PM – 3:30 PM PDT
    Angiogenesis-enabled TME-Chip recreates platelet pathophysiology in resistance to anti-angiogenic therapy against ovarian cancer
    Location: 341 (Center, Level 3)
    Co-Author: Lopamudra Ghosh – Texas A&M University
    Presenting Author: Abhishek Jain, PhD – Texas A&M University
    Cancer Technologies
  • Friday, Oct 13th
    4:00 PM – 5:30 PM PDT
    Engineered Cancer Models for In Vitro Studies II
    Location: 337 (Center, Level 3)
    Track Chair: Jan Lammerding, PhD (he/him/his) – Cornell University
    Track Chair: Jessica Winter – The Ohio State University
    Moderator: Mai Ngo, PhD (she/her/hers) – Boston University
    Moderator: David T. Corr, PhD (he/him/his) – Rensselaer Polytechnic Institute
    Cancer Technologies
  • Friday, Oct 13th
    4:00 PM – 4:15 PM PDT
    A 96-well valved microfluidic device for testing of live intact tumor cuboids
    Location: 337 (Center, Level 3)
    Presenting Author: Ethan Lockhart (he/him/his) – University of Washington
    Co-Author: Lisa Horowitz – Department of Bioengineering, University of Washington
    Co-Author: Chuan Bian Lim – Human Biology Division, Fred Hutchinson Cancer Research Center
    Co-Author: Tran N. H Nguyen, PhD (she/her/hers) – Department of Bioengineering/University of Washington
    Co-Author: Mehdi Mehrabi – Department of Mechanical and Aeronautical Engineering, University of Pretoria
    Co-Author: Taranjit Gujral – Human Biology Division, Fred Hutchinson Cancer Research Center
    Primary Investigator: Albert Folch (he/him/his) – University of Washington
    Cancer Technologies
  • Friday, Oct 13th
    4:15 PM – 4:30 PM PDT
    Assembly and use of microfluidic devices to study nuclear mechanobiology in confined migration
    Location: 337 (Center, Level 3)
    Presenting Author: Richa Agrawal, BS (she/her/hers) – Cornell University
    Co-Author: Aaron Windsor (he/him/his) – Cornell Nanoscale Facility
    Co-Author: Alice-Anais Varlet – Cornell University
    Co-Author: Sarah Henrietta – Cornell University
    Co-Author: Jawuanna McAllister (she/her/hers) – Cornell University
    Co-Author: Margaret Elpers (she/her/hers) – Cornell University
    Primary Investigator: Jan Lammerding, PhD (he/him/his) – Cornell University
    Cancer Technologies
  • Friday, Oct 13th
    4:30 PM – 4:45 PM PDT
    Using Microfluidics to Investigate the Effects of Diet on Tumor Progression
    Location: 337 (Center, Level 3)
    Presenting Author: Molly C. Brennan, MA (she/her/hers) – Department of Chemical and Biological Engineering, Princeton University
    Co-Author: Susan E. Leggett, n/a – Department of Chemical and Biological Engineering, Princeton University
    Co-Author: Bharvi M. Chavre, n/a – Department of Chemistry, Princeton University
    Co-Author: Sherry X. Zhang, n/a – Department of Chemical and Biological Engineering, Princeton University
    Last Author: Celeste M. Nelson – Departments of Chemical and Biological Engineering and Molecular Biology, Princeton University
    Cancer Technologies
  • Friday, Oct 13th
    4:45 PM – 5:00 PM PDT
    Microfluidic models with enhanced tumor vascularization
    Location: 337 (Center, Level 3)
    Presenting Author: Zhengpeng Wan, PhD – MIT
    Co-Author: Marie Floryan – MIT
    Co-Author: David Barbie – Dana-Farber Cancer Institute
    Primary Investigator: Roger Kamm – Massachusetts Institute of Technology
    Cancer Technologies
  • Friday, Oct 13th
    5:00 PM – 5:15 PM PDT
    Developing a microfluidic platform for studying the interaction between perivascular niche and glioblastoma
    Location: 337 (Center, Level 3)
    Presenting Author: Sheridan Fok, MSc (he/him/his) – Department of Bioengineering, University of Illinois Urbana-Champaign
    Co-Author: Yoanna Ivanova – Department of Bioengineering, University of Illinois Urbana-Champaign
    Co-Author: Genesis Rios Adorno (she/her/hers) – Department of Chemical Engineering, University of Illinois Urbana-Champaign
    Primary Investigator: Brendan A.C. Harley – Department of Chemical and Biomolecular Engineering, University of Illinois Urbana Champaign
    Cancer Technologies
  • Friday, Oct 13th
    5:15 PM – 5:30 PM PDT
    Multi-organ Microfluidic Model for Breast Cancer Metastasis
    Location: 337 (Center, Level 3)
    Co-Author: Nelson Lin – SUNY - Binghamton
    Co-Author: Casie Henderson – SUNY - Binghamton
    Co-Author: Emma Drake – SUNY - Binghamton
    Co-Author: Lauren Mehr – SUNY Binghamton
    Co-Author: Leah Andews – SUNY - Binghamton
    Co-Author: Ji Hyun Yang – SUNY - Binghamton
    Co-Author: Xianyang Li – SUNY - Binghamton
    Co-Author: James Coughlin – SUNY - Binghamton
    Presenting Author: Ying Wang – SUNY - Binghamton
    Cancer Technologies